Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD – Get Rating) was the target of a large drop in short interest in March. As of March 31st, there was short interest totalling 26,400 shares, a drop of 28.5% from the March 15th total of 36,900 shares. Based on an average daily trading volume, of 79,700 shares, the short-interest ratio […]
StockNews.com began coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) in a research note issued to investors on Friday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance GLMD opened at $0.32 on Friday. The business’s 50-day simple moving average is $0.47 and its 200-day simple […]
Investment analysts at StockNews.com began coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) in a research report issued on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Trading Down 3.1 % GLMD stock opened at $0.31 on Friday. The business’s 50-day moving average price is $0.48 and […]
StockNews.com started coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) in a report published on Thursday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance Galmed Pharmaceuticals stock opened at $0.34 on Thursday. Galmed Pharmaceuticals has a 12-month low of $0.29 and a 12-month high of […]
StockNews.com began coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Rating) in a research note released on Thursday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance GLMD stock opened at $0.34 on Thursday. Galmed Pharmaceuticals has a 1-year low of $0.29 and a 1-year high of […]